Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul-Aug;70(4):507-10.
doi: 10.4103/0250-474X.44605.

Spectrophotometric determination of certain benzimidazole proton pump inhibitors

Affiliations

Spectrophotometric determination of certain benzimidazole proton pump inhibitors

A A Syed et al. Indian J Pharm Sci. 2008 Jul-Aug.

Abstract

Spectrophotometric method for the determination of certain proton pump inhibitors belonging to the benzimidazole class of compounds has been developed. The method is based on the reaction of omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole with iron (III) and subsequent reaction with ferricyanide under neutral condition which yields Prussian blue product with maximum absorption at 720-730 nm. The commonly encountered excipients and additives that often accompany pharmaceutical preparations did not interfere with the determination. The method was applied for the determination of omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole in pharmaceutical preparations and no difference was found statistically. Thus, the spectrophotometric method can be applied as inexpensive, rapid, easy, accurate and precise method for the routine analysis of the five proton pump inhibitors in pharmaceutical preparations.

Keywords: Benzimidazole; proton pump inhibitors; prussian blue; spectrophotometry.

PubMed Disclaimer

Similar articles

Cited by

References

    1. McClean S, O’Kane E, Ramachandran VN, Smyth WF. Differential pulse polarographic study of the degradation of hydrogen ion/potassium ion ATPase inhibitors SK and F 95601 and omeprozole in acidic media and the subsequent reactions with thiols. Anal Chim Acta. 1994;292:81–9.
    1. Caos A, Moskovitz M, Dayal Y, Perdomo C. Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Am J Gastroenterol. 2000;95:3031–8. - PubMed
    1. Morii M, Takata H, Fujisaki H. The potency of substituted benzimidazoles such as E3810 omeprozole, Ro18-5364 to inhibit gastric H+/K+ ATPase is correlated with the rate of acid-activation of the inhibitor. Biochem Pharmacol. 1990;39:661–7. - PubMed
    1. Radi A, Abd El-Ghany N, Wahdan T. Voltammetric behaviour of rabeprazole at a glassy carbon electrode and its determination in tablet dosage form. Il Farmaco. 2004;59:515–8. - PubMed
    1. Oelschlaeger H, Knoth H. Polarographic analysis of omeprazol formulations: Drug analysis by polarographic methods: Part 38. Pharmazie. 1998;53:242–4.

LinkOut - more resources